ADM Korea Inc.

Penetrium Bioscience Inc. is a contract research organization based in Seoul, South Korea, providing clinical-related professional services. Its offerings include clinical development services such as medical writing, clinical operations, late phase studies, data management, biostatistics, and regulatory affairs. It also provides pharmacovigilance services, including case processing, safety reporting, safety and risk management plans, aggregate reporting, literature screening, and medical device vigilance, as well as quality assurance services. The company was formerly known as Hyundai ADM Bio Inc. and changed its name to Penetrium Bioscience Inc. in March 2026. It was founded in 2003.